1. Mulliken JB, Fishman SJ, Burrows PE: Vascular anomalies. Curr Probl Surg 37:517, 2000
2. Enjolras O, Mulliken JB: Vascular tumors and vascular malformations: New issues. Adv Dermatol 13:375, 1997
3. Hand JL, Frieden IJ: Vascular birthmarks of infancy: Resolving nosologic confusion. Am J Med Genet 108:257, 2002
4. Frieden IJ et al: Infantile hemangiomas: Current knowledge, future directions. Proceedings of a research workshop on infantile hemangiomas, April 7–9, 2005, Bethesda, Maryland, USA. Pediatr Dermatol 22:383, 2005
5. Kilcline C, Frieden IJ: Infantile hemangiomas: How common are they? A systematic review of the literature. Pediatr Dermatol 25:168, 2008
6. Haggstrom AN et al: Prospective study of infantile hemangiomas: Demographic, prenatal, and perinatal characteristics. J Pediatr 150:291, 2007
7. Drolet BA, Swanson EA, Frieden IJ: Infantile hemangiomas: An emerging health issue linked to an increased rate of low birth weight infants. J Pediatr 153:712, 2008
8. Garzon MC et al: Comparison of infantile hemangiomas in preterm and term infants: A prospective study. Arch Dermatol 144:1231, 2008
9. Boye E, Jinnin M, Olsen BR: Infantile hemangioma: Challenges, new insights, and therapeutic promise. J Craniofac Surg 20(Suppl 1):678, 2009
10. Bischoff J: Progenitor cells in infantile hemangioma. J Craniofac Surg 20(Suppl 1):695, 2009
11. Boscolo E, Bischoff J: Vasculogenesis in infantile hemangioma. Angiogenesis 12:197, 2009
12. Chang EI et al: Hypoxia, hormones, and endothelial progenitor cells in hemangioma. Lymphat Res Biol 5:237, 2007
13. Barnés CM, Christison-Lagay EA, Folkman J: The placenta theory and the origin of infantile hemangioma. Lymphat Res Biol 5:245, 2007
14. Haggstrom AN et al: Patterns of infantile hemangiomas: New clues to hemangioma pathogenesis and embryonic facial development. Pediatrics 117:698, 2006
15. North PE et al: GLUT1: A newly discovered immunohistochemical marker for juvenile hemangiomas. Hum Pathol 31:11, 2000
16. North PE et al: A unique microvascular phenotype shared by juvenile hemangiomas and human placenta. Arch Dermatol 137:559, 2001
17. Barnes CM et al: Evidence by molecular profiling for a placental origin of infantile hemangioma. Proc Natl Acad Sci USA 102:19097, 2005
18. Bree AF et al: Infantile hemangiomas: Speculation on placental trophoblastic origin. Arch Dermatol 137:573, 2001
19. Pittman KM et al: No evidence for maternal-fetal microchimerism in infantile hemangioma: A molecular genetic investigation. J Invest Dermatol 126:2533, 2006
20. Dadras SS et al: Infantile hemangiomas are arrested in an early developmental vascular differentiation state. Mod Pathol 17:1068, 2004
21. Kleinman ME et al: Hypoxia-induced mediators of stem/progenitor cell trafficking are increased in children with hemangioma. Arterioscler Thromb Vasc Biol 27:2664, 2007
22. Yu Y et al: Endothelial progenitor cells in infantile hemangioma. Blood 103:1373, 2004
23. Khan ZA et al: Multipotential stem cells recapitulate human infantile hemangioma in immunodeficient mice. J Clin Invest 118:2592, 2008
24. Walter JW, North PE, Waner M: Somatic mutation of vascular endothelial growth factor receptors in juvenile hemangioma. Genes Chromosomes Cancer 33:295, 2002
25. Jinnin M et al: Suppressed NFAT-dependent VEGFR1 expression and constitutive VEGFR2 signaling in infantile hemangioma. Nat Med 14:1236, 2008
26. Boye E et al: Clonality and altered behavior of endothelial cells from hemangiomas. J Clin Invest 107:745, 2001
27. Berg JN et al: Evidence for loss of heterozygosity of 5q in sporadic haemangiomas: Are somatic mutations involved in haemangioma formation? J Clin Pathol 54:249, 2001
28. Bruckner AL, Frieden IJ: Hemangiomas of infancy. J Am Acad Dermatol 48:477, 2003
29. Chang LC et al: Growth characteristics of infantile hemangiomas: Implications for management. Pediatrics 122:360, 2008
30. Brandling-Bennett HA et al: Infantile hemangiomas with unusually prolonged growth phase. Arch Dermatol 144:1632, 2008
31. Waner M et al: The nonrandom distribution of facial hemangiomas. Arch Dermatol 139:869, 2003
32. Chiller KG, Passaro D, Frieden IJ: Hemangiomas of infancy: Clinical characteristics, morphologic subtypes, and their relationship to race, ethnicity, and sex. Arch Dermatol 138:1567, 2002
33. Happle R: Superimposed segmental hemangioma of infancy. Dermatology 220:180, 2010
34. Haggstrom AN et al: Prospective study of infantile hamangiomas: Clinical characteristics predicting complications and treatment. Pediatrics 118:882, 2006
35. Corella F et al: Abortive or minimal-growth hemangiomas: Immunohistochemical evidence that they represent true infantile hemangiomas. J Am Acad Dermatol 58:685, 2008
36. Suh KY, Frieden IJ: Infantile hemangiomas with minimal or arrested growth: a retrospective case series. Arch Dermatol 146(9):971-976, 2010
37. Frieden IJ, Reese V, Cohen D: PHACE syndrome. Arch Dermatol 132:307, 1996
38. Metry DW et al: PHACE syndrome: Current knowledge, future directions. Pediatr Dermatol 26:381, 2009
39. Metry D et al: Consensus statement on diagnostic criteria for PHACE syndrome. Pediatrics 124:1447, 2009
40. Metry DW et al: The many faces of PHACE syndrome. J Pediatr 139:117, 2001
41. Bhattacharya JJ et al: PHACES syndrome: A review of eight previously unreported cases with late arterial occlusions. Neuroradiology 46:227, 2004
42. Drolet BA, Dohil M, Golomb MR: Early stroke and cerebral vasculopathy in children with facial hemangiomas and PHACE Association. Pediatrics 117:959, 2006
43. Burrows PE et al: Cerebral vasculopathy and neurologic sequelae in infants with cervicofacial hemangioma: Report of eight patients. Radiology 207:601, 1998
44. Ceisler EJ, Santos L, Blei F: Periocular hemangiomas: What every physician should know. Pediatr Dermatol 21:1, 2004
45. Schwartz SR et al: Risk factors for amblyopia in children with capillary hemangiomas of the eyelids and orbit. J AAPOS 10:262, 2006
46. Orlow SJ, Isakoff MS, Blei F: Increased risk of symptomatic hemangiomas of the airway in association with cutaneous hemangiomas in a “beard” distribution. J Pediatr 131:643, 1997
47. Rahbar R et al: The biology and management of subglottic hemangioma: Past, present, future. Laryngoscope 114:1880, 2004
48. Greene AK, Rogers GF, Mulliken JB: Management of parotid hemangioma in 100 children. Plast Reconstr Surg 113:53, 2004
49. Reinisch JF, Kim RY, Harshbarger RJ: Surgical management of parotid hemangioma. Plast Reconstr Surg 113:1940, 2004
50. Girard C et al: PELVIS syndrome. Arch Dermatol 142:884, 2006
51. Stockman A et al: SACRAL syndrome: Spinal dysraphism, anogenital, cutaneous, renal and urologic anomalies, associated with an angioma of lumbosacral localization. Dermatology 214:40, 2007
52. Tubbs RS et al: Isolated flat capillary midline lumbosacral hemangiomas as indicators of occult spinal dysraphism. J Neurosurg Spine 100:86, 2004
53. Metry DW et al: Association of solitary, segmental hemangiomas of the skin with visceral hemangiomatosis. Arch Dermatol 140:591, 2004
54. Hughes JA et al: Cutaneous hemangioma: Prevalence and sonographic characteristics of associated hepatic haemangioma. Clin Radiol 59:273, 2004
55. Christison-Lagay ER et al: Hepatic hemangiomas: Subtype classification and development of a clinical practice algorithm and registry. J Pediatr Surg 42:62, 2007
56. Kassarjian A, Dubois J, Burrows PE: Angiographic classification of hepatic hemangiomas in infants. Radiology 222:693, 2002
57. Kassarjian A et al: Infantile hepatic hemangiomas: Clinical and imaging findings and their correlation with therapy. Am J Radiol 182:785, 2004
58. Ho J et al: New insight into the pathophysiology of severe hypothyroidism in an infant with multiple hepatic hemangiomas. J Pediatr Endocrinol Metab 18:511, 2005
59. Ayling RM et al: Hepatic hemangioendothelioma associated with production of humoral thyrotropin-like factor. J Pediatr 138:932, 2001
60. Konrad D, Ellis G, Perlman K: Spontaneous regression of severe acquired infantile hypothyroidism associated with multiple liver hemangiomas. J Pediatr 112:1424, 2003
61. Huang SA et al: Severe hypothyroidism caused by type 3 iodothyronine deiodinase in infantile hemangiomas. N Engl J Med 343:185, 1994
62. Poindexter G et al: PHACE syndrome with intracerebral hemangiomas, heterotopia, and endocrine dysfunction. Pediatr Neurol 36:402, 2007
63. Chamlin S et al: Multicenter prospective study of ulcerated hemangiomas. J Pediatr 151:684, 2007
64. Kim HJ, Colombo M, Frieden IJ: Ulcerated hemangiomas: Clinical characteristics and response to therapy. J Am Acad Dermatol 44:962, 2001
65. Brook I: Microbiology of infected hemangiomas in children. Pediatr Dermatol 21:113, 2004
66. Oranje AP et al: Treatment and pain relief of ulcerative hemangiomas with a polyurethane film. Dermatology 200:31, 2000
67. Yan A: Pain management for ulcerated hemangiomas. Pediatr Dermatol 25:586, 2008
68. Sugarman JL, Mauro TM, Frieden IJ: Treatment of an ulcerated hemangioma with recombinant platelet-derived growth factor. Arch Dermatol 138:314, 2002
69. Metz BJ et al: Response of ulcerated perineal hemangiomas of infancy to
becaplermin gel, a recombinant human platelet-derived growth factor.
Arch Dermatol 140:867, 2004
70. Metry DW: Potential complications of segmental hemangiomas of infancy. Semin Cutan Med Surg 23:107, 2004
71. Tanner JL, Dechert MP, Frieden IJ: Growing up with a facial hemangioma; parent and child coping and adaptation. Pediatrics 101:446, 1998
72. Williams EF3rd et al: A psychological profile of children with hemangiomas and their families. Arch Facial Plast Surg 5:229, 2003
73. Gleason T: Summer's strawberry. J Am Acad Dermatol 51:S53, 2004
74. Greig AV, Harris DL: A study of perceptions of facial hemangiomas in professionals involved in child abuse surveillance. Pediatr Dermatol 20:1, 2003
75. Al-Sebeih K, Manoukian J: Systemic steroids for the management of obstructive subglottic hemangioma. J Otolaryngol 29:361, 2000
76. Hasan Q et al: Altered mitochondrial cytochrome b gene expression during the regression of hemangioma. Plast Reconstr Surg 108:1471, 2001
77. Hasan Q et al: Steroid therapy of a proliferating hemangioma: Histochemical and molecular changes. Pediatrics 105:117, 2000
78. Hasan Q et al: Effects of five commonly used glucocorticoids on haemangioma in vitro. Clin Exp Pharmacol Physiol 30:140, 2003
79. Bennett ML et al: Oral corticosteroid use is effective for cutaneous hemangiomas. Arch Dermatol 137:1208, 2001
80. Boon LM, MacDonald DM, Mulliken JB: Complications of systemic corticosteroid therapy for problematic hemangiomas. Plast Reconstr Surg 104:1616, 1999
81. Lomenick JP, Backeljauw PF, Lucky AW: Growth, bone mineral accretion, and adrenal function in glucocorticoid-treated infants with hemangiomas—A retrospective study. Pediatr Dermatol 23:169, 2006
82. Lomenick JP et al: Prevalence of adrenal insufficiency following systemic glucocorticoid therapy in infants with hemangiomas. Arch Dermatol 145:262, 2009
83. George ME et al: Adverse effects of systemic glucocorticosteroid therapy in infants with hemangiomas. Arch Dermatol 140:963, 2004
84. Aviles R, Boyce TG, Thompson DM: Pneumocystis carinii pneumonia in a 3-month-old infant receiving high-dose corticosteroid therapy for airway hemangiomas. Mayo Clin Proc 79:243, 2004
85. Maronn ML, Corden T, Drolet BA: Pneumocystis carinii pneumonia in infant treated with oral steroids for hemangioma. Arch Dermatol 143:1224, 2007
86. O'Keefe M, Lanigan B, Byrne SA: Capillary haemangioma of the eyelids and orbit: A clinical review of the safety and efficacy of intralesional steroid. Acta Ophthalmol Scand 81:294, 2003
87. Egbert JE et al: High injection pressure during intralesional injection of corticosteroids into capillary hemangiomas. Arch Ophthalmol 119:677, 2001
88. Chen MT, Yeong EK, Horng SY: Intralesional corticosteroid therapy in proliferating head and neck hemangiomas: A review of 155 cases. J Pediatr Surg 35:420, 2000
89. Cruz OA, Zarnegar SR, Myers SE: Treatment of periocular capillary hemangioma with topical
clobetasol propionate.
Ophthalmology 102:2012, 1995
90. Garzon MC et al: Ultrapotent topical corticosteroid treatment of hemangiomas of infancy. J Am Acad Dermatol 52:281, 2005
91. Léauté-Labrèze C et al:
Propranolol for severe hemangiomas of infancy.
N Engl J Med 358:2649, 2008
92. Hogeling M, Adams S, Wargon O: A randomized controlled trial of
propranolol for infantile hemangiomas.
Pediatrics 128(2):e259-266, 2011
93. Price CJ, Lattouf C, Baum B, McLeod M, Schachner LA, Duarte AM, Connelly EA:
Propranolol vs Corticosteroids for Infantile Hemangiomas: A Multicenter Retrospective Analysis.
Arch Dermatol 2011 Aug 15.
[PubMed: 21844428]
94. Lawley LP, Siegfried E, Todd JL:
Propranolol treatment for hemangioma of infancy: Risks and recommendations.
Pediatr Dermatol 26:610, 2009
95. Frieden IJ, Drolet BA:
Propranolol for infantile hemangiomas: Promise, peril, pathogenesis.
Pediatr Dermatol 26:642, 2009
96. Marsciani A et al: Massive response of severe infantile hepatic hemangioma to propanolol. Pediatr Blood Cancer 54:176, 2010
97. Fay A et al:
Propranolol for isolated orbital infantile hemangioma.
Arch Ophthalmol 128:256, 2010
98. Buckmiller L, Dyamenahalli U, Richter GT:
Propranolol for airway hemangiomas: Case report of novel treatment.
Laryngoscope 119:2051, 2009
99. Storch CH, Hoeger PH:
Propranolol for infantile haemangiomas: insights into the molecular mechanisms of action.
Br J Dermatol 163(2):269-274, 2010
100. Guo S, Ni N: Topical treatment for capillary hemangioma of the eyelid using β-blocker solution. Arch Ophthalmol 128:255, 2010
101. Ni N, Langer P, Wagner R, Guo S: Topical
timolol for periocular hemangioma: report of further study.
Arch Ophthalmol 129(3):377-379, 2011
102. Pope E, Chakkittakandiyil A: Topical
timolol gel for infantile hemangiomas: a pilot study.
Arch Dermatol 146(5):564-565, 2010
103. Michaud AP et al: Spastic diplegia and other motor disturbances in infants receiving interferon-alpha. Laryngoscope 114:1231, 2004
104. Perez J, Pardo J, Gomez C: Vincristine—An effective treatment of corticoid-resistant life-threatening infantile hemangiomas. Acta Oncol 41:197, 2002
105. Fawcett SL et al:
Vincristine as a treatment for a large haemangioma threatening vital functions.
Br J Plast Surg 57:168, 2004
106. Moore J et al: Effective therapy of a vascular tumor of infancy with
vincristine.
J Ped Surg 36:1273, 2001
107. Hurvitz SA et al: Successful treatment with
cyclophosphamide of life-threatening diffuse hemangiomatosis involving the liver.
J Pediatr Hematol Oncol 22:527, 2000
108. McCuaig CC et al: A phase II, open-label study of the efficacy and safety of
imiquimod in the treatment of superficial and mixed infantile hemangioma.
Pediatr Dermatol 26:203, 2009
109. Ho NT, Lansang P, Pope E: Topical
imiquimod in the treatment of infantile hemangiomas: A retrospective study.
J Am Acad Dermatol 56:63, 2007
110. Morelli JG et al: Treatment of ulcerated hemangiomas in infancy. Arch Pediatr Adolesc Med 148:1104, 1994
111. Batta K et al: Randomized controlled study of early pulsed dye laser treatment of uncomplicated childhood haemangiomas: Results of a 1-year analysis. Lancet 320:521, 2002
112. David LR, Malek MM, Argenta LC: Efficacy of pulse dye laser therapy for the treatment of ulcerated haemangiomas: A review of 78 patients. Br J Plast Surg 56:317, 2003
113. Michel JL: Treatment of hemangiomas with 595 nm pulsed dye laser dermobeam. Eur J Dermatol 13:136, 2003
114. Hohenleutner U, Landthaler M: Laser treatment of childhood haemangioma: Progress or not? Lancet 360:502, 2002
115. Kolde G: Early pulsed-dye laser treatment of childhood haemangiomas. Lancet 361:348, 2003
116. Kono T et al: Comparison study of a traditional pulsed dye laser versus a long-pulsed dye laser in the treatment of early childhood hemangiomas. Lasers Surg Med 38:112, 2006
117. Rizzo C et al: Outcomes of childhood hemangiomas treated with the pulsed-dye laser with dynamic cooling: A retrospective chart analysis. Dermatol Surg 35:1947, 2009
118. Witman PM et al: Complications following pulsed dye laser treatment of superficial hemangiomas. Lasers Surg Med 38:116, 2006
119. Anderson RR: Infant hemangiomas: A controversy worth solving. Lasers Surg Med 38:92, 2006
120. McHeik JN et al: Surgical treatment of haemangioma in infants. Br J Plast Surg 58:1067, 2005
121. Demiri
EC et al: Treatment of facial haemangiomas: The present status of surgery.
Br J Plast Surg 54:665, 2001
122. Denk MJ et al: Surgical treatment of nasal hemangiomas. Ann Plast Surg 48:489, 2002
123. Hochman M, Mascareno A: Management of nasal hemangiomas. Arch Facial Plast Surg 7:295, 2005
124. Faguer K et al: Early surgical treatment of Cyrano-nose haemangiomas with rethi incision. Br J Plast Surg 55:498, 2002
125. McCarthy JG, Borud LJ, Schreiber JS: Hemangiomas of the nasal tip. Plast Reconstr Surg 109:31, 2002
126. Warren SM, Longaker MT, Zide BM: The subunit approach to nasal tip hemangiomas. Plast Reconstr Surg 109:25, 2002
127. Mulliken JB, Rogers GF, Marler JJ: Circular excision of hemangioma and purse-string closure: The smallest possible scar. Plast Reconstr Surg 109:1544, 2002
128. Requena L, Sangueza OP: Cutaneous vascular proliferation. Part II. Hyperplasias and benign neoplasms. J Am Acad Dermatol 37:887, 1997
129. Weiss SW, Goldblum JR: Benign tumors and tumor-like lesions of blood vessels. In: Enzinger and Weiss's Soft Tissue Tumors, 4th edition, edited by SW Weiss, JR Goldblum. St Louis, Mosby Inc, 2001 p. 837 and 891
130. Weiss SW, Goldblum JR: Hemangioendothelioma: Vascular tumors of intermediate malignancy. In: Enzinger and Weiss's Soft Tissue Tumors, 4th edition, edited by SW Weiss, JR Goldblum. St Louis, Mosby Inc, 2001, p. 891
131. Krol A, MacArthur CJ: Congenital hemangiomas: Rapidly involuting and noninvoluting congenital hemangiomas. Arch Facial Plast Surg 307:11, 2005
132. Berenguer B et al: Rapidly involuting congenital hemangioma: Clinical and histopathologic features. Pediatr Dev Pathol 6:495, 2003
133. North PE et al: Congenital nonprogressive hemangioma: A distinct clinicopathologic entity unlike infantile hemangioma. Arch Dermatol 137:1607, 2001
134. Boon LM, Enjolras O, Mulliken JB: Congenital hemangioma: Evidence of accelerated involution. J Pediatr 128:329, 1996
135. Ozcan UA: Rapidly involuting congenital hemangioma: A case of complete prenatal involution. J Clin Ultrasound 38:85, 2010
136. Maronn M, Chamlin S, Metry D: Multifocal tufted angiomas in 2 infants. Arch Dermatol 145:847, 2009
137. Ishikawa K et al: The spontaneous regression of tufted angioma. A case of regression after two recurrences and a review of 27 cases reported in the literature. Dermatology 210:346, 2005
138. Wilson-Jones E, Orkin M: Tufted angioma (angioblastoma): A benign progressive angioma not to be confused with Kaposi's sarcoma or low grade angiosarcoma. J Am Acad Dermatol 20:214, 1989
139. Arai E et al: Usefulness of D2–40 immunohistochemistry for differentiation between kaposiform hemangioendothelioma and tufted angioma. J Cutan Pathol 33:492, 2006
140. Browning J et al: Congenital, self-regressing tufted angioma. Arch Dermatol 142:749, 2006
141. O'Regan GM et al: Mediastinal and neck kaposiform hemangioendothelioma: Report of three cases. Pediatr Dermatol 26:331, 2009
142. Gruman A et al: Kaposiform hemangioendothelioma without Kasabach-Merritt phenomenon. J Am Acad Dermatol 52:616, 2005
143. Lyons LL et al: Kaposiform hemangioendothelioma. A study of 33 cases emphasizing its pathologic, immunophenotypic, and biologic uniqueness from juvenile hemangioma. Am J Surg Pathol 28:559, 2004
144. Folpe AL et al: Vascular endothelial growth factor receptor-3 (VEGFR-3): A marker of vascular tumors with presumed lymphatic differentiation, including Kaposi's sarcoma, kaposiform and Dabska-type hemangioendotheliomas, and a subset of angiosarcomas. Mod Pathol 13:180, 2000
145. Debelenko LV et al: D2–40 immunohistochemical analysis of pediatric vascular tumors reveals positivity in kaposiform hemangioendothelioma. Mod Pathol 18:1454, 2005
146. Enjolras O et al: Infants with Kasabach-Merritt syndrome do not have “true” hemangiomas. J Pediatr 130:631, 1997
147. Sarkar M et al: Thrombocytopenic coagulopathy (Kasabach-Merritt phenomenon) is associated with kaposiform hemangioendothelioma and not with common infantile hemangioma. Plast Reconstr Surg 100:1377, 1997
148. Mazoyer E et al: Coagulation abnormalities associated with extensive venous malformations of the limbs: Differentiation from Kasabach-Merritt syndrome. Clin Lab Haematol 24:243, 2002
149. Enjolras O et al: Residual lesions after Kasabach-Merritt phenomenon in 41 patients. J Am Acad Dermatol 42:225, 2000
150. Hauer J et al: Effective treatment of kaposiform hemangioendotheliomas associated with Kasabach-Merritt phenomenon using four-drug regimen. Pediatr Blood Cancer 49:852, 2007
151. Haisley-Royster C et al: Kasabach-Merritt phenomenon: A retrospective study of treatment with
vincristine.
J Pediatr Hematol Oncol 24:459, 2002
152. Drucker AM et al:
Vincristine and corticosteroids as first-line treatment of Kasabach-Merritt syndrome in kaposiform hemangioendothelioma.
J Cutan Med Surg 13:155, 2009
153. López V et al: Successful management of kaposiform hemangioendothelioma with kasabach-merritt phenomenon using
vincristine and
ticlopidine.
Pediatr Dermatol 26:365, 2009
154. Rodriguez V et al: Kasabach-merritt phenomenon: Case series and retrospective review of the mayo clinic experience. J Pediatr Hematol Oncol 31:522, 2009
155. Maronn M et al: Expanding the phenotype of multifocal lymphangioendotheliomatosis with thrombocytopenia. Pediatr Blood Cancer 52:531 2009
156. North PE et al: Multifocal lymphangioendotheliomatosis with thrombocytopenia: A newly recognized clinicopathological entity. Arch Dermatol 140:599, 2004
157. Prasad V et al: Cutaneovisceral angiomatosis with thrombocytopenia. Pediatr Dev Pathol 8:407, 2005
158. Kline RM, Buck LM:
Bevacizumab treatment in multifocal lymphangioendotheliomatosis with thrombocytopenia.
Pediatr Blood Cancer 52:534, 2009
159. Perkins P, Weiss SW: Spindle cell hemangioendothelioma: An analysis of 78 cases with reassessment of its pathogenesis and biologic behavior. Am J Surg Pathol 20:1196, 1996
160. Nakatsui
TC et al: Eccrine angiomatous hamartoma: Report of a case and literature review.
J Am Acad Dermatol 41:109, 1999
161. Frieden IJ, Esterly NB: Pyogenic granulomas of infancy masquerading as strawberry hemangiomas. Pediatrics 90:989, 1992
162. Tritton SM et al: Pyogenic granuloma in ten children treated with topical
imiquimod.
Pediatr Dermatol 26:269, 2009
163. Patrice SJ, Wiss K, Mulliken JB: Pyogenic granuloma (lobular capillary hemangioma): A clinicopathologic study of 178 cases. Pediatr Dermatol 8:267, 1991
164. Pagliai KA, Cohen BA: Pyogenic granuloma in children. Pediatr Dermatol 21:10, 2004